The present invention relates generally to the field of medical devices, and in particular to an apparatus and method for suspending a uterus of a human or animal subject.
Many women with uterine prolapse would like for their condition to be surgically corrected, but avoid or delay undergoing an operation because they wish to avoid hysterectomy. The potential reasons for avoiding hysterectomy vary widely including plans for future childbearing, concern about the invasiveness of the procedure or the difficulty of the recuperation, or fear of diminished sexual function. Some women are simply reluctant to “give up” this part of their body so closely associated with their reproductive health, childbearing, and femininity.
Uterine prolapse can be effectively treated without hysterectomy, with low morbidity and high rates of patient satisfaction. A properly performed uterine suspension surgery often results in a significantly better anatomic outcome than hysterectomy. Yet, many hysterectomy procedures are performed for pelvic prolapse. One reason why most patients remain unaware of the uterine-sparing option is because with the exception of a few dedicated sub-specialists, most surgeons receive no training in these techniques. In addition, known techniques and equipment can be difficult and require involved specialized training that many general practitioners have not undertaken.
Thus a need exists for an improved apparatus and method for providing a minimally invasive hysteropexy that can be incorporated into mainstream gynecologic practice.
An apparatus, method and kit for performing a uterine suspension procedure are disclosed herein. In one embodiment, an inter-vaginal device for performing a uterine suspension includes a rigid body for manipulating the uterus and implanting a suspension member, such as a mesh, for securing the uterus to an anchoring site (e.g., into a pelvic muscle or ligament). In another embodiment, a method includes inserting at least a portion of a uterine suspension member through an anterior or posterior vaginal incision. An end of the suspension member is anchored to a selected portion of a pelvic tissue with anchoring methods that may include tying off with sutures, or directly affixing the suspension member to the pelvic tissue with, for example, self-affixing mesh arms. At least a portion of the suspension member can be attached to a vaginal apex or adjacent to the vaginal apex to further facilitate scarring. A uterine manipulator can be advanced in a direction toward the selected portion of the pelvic tissue such that at least a portion of a uterus is moved upward.
The invention may be understood more readily by reference to the following detailed description of the invention taken in connection with the accompanying drawing figures, which form a part of this disclosure. It is to be understood that this invention is not limited to the specific devices, methods, conditions or parameters described and/or shown herein, and that the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting of the claimed invention. Also, as used in the specification including the appended claims, the singular forms “a,” “an,” and “the” include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment.
In some embodiments, the invention includes a device for performing a uterine suspension comprising a substantially rigid body having a handle at a distal end thereof; a lumen through the substantially rigid body for housing sutures of a suspension member; and a uterine manipulator at a proximal end thereof. The uterine manipulator can further include a prong for insertion into the uterus; a tenaculum clip for securing the uterine manipulator to the cervix; and a pair of wings for aiding in securing the suspension member to the vagina. Optionally, the uterine suspension device can be included in a kit, along with a mesh or graft for a cystocele and/or a rectocele augmentation.
In another embodiment the invention includes a method of performing a uterine suspension. The method can include the steps of making an anterior or posterior vaginal incision; palpating ischial spines bilaterally; inserting the suspension member through the vaginal incision; placing suspension sutures of the suspension member or a portion of the suspension member (e.g., self-affixing tanged mesh) into a sacrospinous or iliococcygeus anchoring site; inserting the uterine manipulator through the cervix and securing it thereto; fastening the suspension member to the corners of the vaginal apex or placing the suspension member adjacent to the vaginal apex; applying gentle traction on the sutures or the self-affixing mesh; advancing the uterine manipulator to the anchoring site; removing the device; tying the sutures or adjusting the self-affixing mesh to the appropriate tension; and closing the vaginal incision.
In still another embodiment, the invention includes a suspension member, the suspension member includes at least one suture having an anchoring member at a first end and a free end for manipulation by a practitioner, wherein the suture is woven through the suspension member for providing accordion-type folds. In some embodiments, the suspension member is constructed of a self-affixing mesh material requiring passage of mesh arms rather than sutures through the pelvic tissue/anchoring site.
Advantageously, the device of the invention will introduce a minimally invasive, uterinesparing prolapse surgery that can be incorporated into mainstream gynecologic practice. The device can provide an effective, simple and reproducible uterine suspension technique for general gynecologic surgeons. The procedures described herein have the potential to attract countless women with uterine prolapse who would otherwise have avoided an operation, and increase the market of women choosing the described surgery for treatment of their prolapsed condition.
These and other aspects, features and advantages of the invention will be understood with reference to the drawing figures and detailed description herein, and will be realized by means of the various elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the brief description of the drawings and detailed description of the invention are exemplary and explanatory of some embodiments of the invention, and are not restrictive of the invention, as claimed.
The suspension device 110 can be used to help secure a uterine suspension member 120 within a pelvic region P of a patient. A suspension member 120 can be formed, for example, with a mesh material and configured to be anchored on one end to a pelvic tissue T1 such as a sacrospinous ligament or a levator muscle, such as the iliococcygeus muscle, and on another end to a pelvic tissue T2 disposed on an opposite side of the uterus of the patient. Another portion of the suspension member 120 can be configured to be attached to a vaginal apex V of the patient. An example embodiment of a suspension member 20 is described in more detail below with reference to
With reference now to
The substantially rigid body 12 is used to implant a suspension member 20 around the uterus so as to secure the uterus to a muscle or ligament in the deep pelvic area. The body 12 can be constructed of an inert and biocompatible material such as, for example, a metal such as titanium or stainless steel or a plastic, although those skilled in the art will understand that various materials can be employed without deviating from the scope of the present invention. The rigid body 12 can be reusable or it can be disposable. If the body is reusable, then the materials of construction are preferably autoclavable or otherwise capable of sterilization.
The suspension member 20 is configured generally in the shape of a “U” having a pair of arms 22 and 24. The suspension member 20 can be formed, for example, of polypropylene or prolene mesh, although those skilled in the art will understand that various other biocompatible and biologically inert materials can be used as well for the suspension member 20. Additionally, the suspension member 20 may not be a “mesh” but instead be a band of an inert and biologically compatible material.
At least one, and preferably two tensioning sutures 26 and 28 are woven into the suspension member 20 for providing a suspension member with an accordion-type design (or accordion-type folds). A first anchor 30 is located at the proximal end of the suture 26, and a second anchor 32 is located at the proximal end of the suture 28. The anchors 30 and 32 anchor or attach the sutures 26 and 28 to an anchoring site, which is typically a pelvic muscle or ligament. The distal ends of the pair of sutures 26 and 28 are woven into the suspension member 20 and pass through a lumen 29 through the shaft 14 and out of the body 12 of the device 10 near the handle 16 so that the practitioner can manipulate the sutures with one hand while gripping the handle 16 with the other hand to manipulate the uterus.
The uterine manipulator portion 18 can include a substantially rigid prong 34 for insertion through the cervix into the uterus, a tenaculum (or a tenaculum clip) 36 with a sharp point for securing the uterine manipulator to the cervix, and an anchoring member 44 having a pair of wings 38 and 40 for anchoring the suspension member 20 to the vagina, can be coupled to the uterine manipulator 18. The wings 38 and 40 can be constructed of a malleable, “shapememory” plastic, which allows for a comfortable fit into the vaginal fornices. Also, the wings 38 and 40 can each include at least one, and in some embodiments, a plurality of apertures 42 therein so that the practitioner can connect or suture the suspension member 20 to the vagina through the apertures. The wings 38 and 40 spread into the lateral corners of the vagina so that the suspension member 20 can be secured to the vagina.
In one embodiment, a method of performing a vaginal uterine suspension begins by administering anesthesia to the patient. For example, either a general anesthesia or an epidural anesthesia can be used. A practitioner makes an anterior or posterior vaginal incision, performs a standard anterior colporrhaphy dissection, and palpates the ischial spines bilaterally, all of which are generally well known to those skilled in the art. As the uterine suspension device 10 is inserted into the vagina, the practitioner inserts the suspension member 20 through the anterior (or posterior) vaginal incision. The ends of the suspension member 20, i.e., the sutures 26 and 28, are anchored in a pelvic muscle or ligament such that the suspension member generally surrounds the uterus. In some embodiments, the first suture 28 with anchor 32 is anchored into the sacrospinous ligament or the levator muscle (such as the iliococcygeus muscle) and the second suture 26 with anchor 30 is anchored into the sacrospinous or levator muscle on the opposite side, as depicted in
The prong 34 of the uterine manipulator 18 is inserted through the cervix into the uterus and is fastened thereto with the tenaculum clip 36. In so doing, the wings 38 and 40 coupled to the device 10 are positioned into the lateral corners of the vaginal apex. The suspension member 20 is fastened to the corners of the vaginal apex by suturing the suspension member 20 to the inside of the vagina through the apertures 42 in the wings 38 and 40. For example, sutures can be placed 2 cm lateral to the midline on each side. Optionally, the practitioner can use bioabsorbable anchors or sutures to secure the suspension member 20 to the vagina. Also optionally, if an augmentation is planned, an anterior or posterior graft can be secured with the same anchors at the vaginal apical corners.
The practitioner applies gentle traction on the sutures 26 and 28 (i.e., pulling the sutures rearwardly from the device 10) while simultaneously slowly advancing the uterine manipulator 18 in a direction generally towards the anchoring site e.g., the sacrospinous ligament or the iliococcygeus muscle). In so doing, the cervix along with the uterus is pushed up while the suspension member 20 shortens because of its accordion design and recreates the cardinaluterosacral attachments between the vaginal apex and the pelvic sidewall. The practitioner removes the device 10, withdrawing it over the sutures 26 and 28, which are held at constant tension. The practitioner ties the sutures 26 and 28, without tension, leaving them inside the vaginal incision. The vagina is closed after completion of anterior compartment repair (i.e. colporrhaphy, graft placement).
At 64, at least a portion of the suspension member is attached to a vaginal apex. In some embodiments, the attaching the at least a portion of the suspension member to the vaginal apex includes at 66, coupling an anchoring member disposed within an interior of the vagina to the suspension member such that a portion of a wall of the vagina is disposed between the suspension member and the anchoring member. In some embodiments, the attaching at least a portion of the suspension member to the vaginal apex includes attaching the suspension member at a first corner of the vaginal apex and attaching the suspension member at a second corner of the vaginal apex. In some embodiments, the suspension member has a first end and a second end, and the second end of the suspension member is anchored to a second selected portion of a pelvic tissue on an opposite side of the uterus at 68.
At 70, a uterine manipulator can be optionally advanced in a direction toward the selected portion of tissue such that at least a portion of a uterus is moved upward. At 72, in some embodiments, simultaneously with the advancing the uterine manipulator, traction is applied to a suture coupled to the suspension member.
In some embodiments, a kit can be provided that includes at least one suspension member, such as suspension member 20, and a medical device, such as suspension device 10. The suspension member can have an end configured to be anchored to a pelvic tissue within a patient and a portion configured to be attached to a vaginal apex of the patient. The medical device can be used during a uterine suspension procedure to assist in securing the suspension member within a pelvic region of the patient. A kit can also include an anchoring member, such as anchoring member 44, configured to be disposed within an interior of a vagina of the patient and coupleable to the suspension member to help secure the suspension member to the vagina. A kit can also include at least one mesh or a graft to be used in a procedure such as a cystocele or rectocele augmentation.
While various embodiments of the invention have been described above, it should be understood that they have been presented by way of example only, and not limitation. Thus, the breadth and scope of the invention should not be limited by any of the above-described embodiments, but should be defined only in accordance with the following claims and their equivalents.
The previous description of the embodiments is provided to enable any person skilled in the art to make or use the invention. While the invention has been particularly shown and described with reference to embodiments thereof, it will be understood by those skilled in art that various changes in form and details may be made therein without departing from the spirit and scope of the invention.
For example, a variety of different suspension members 20 can be used in any of the uterine suspension procedures described herein. A suspension member can be a variety of different configurations, shapes and/or sizes and be formed with various different materials not specifically described. The suspension device 10 can include any combination or subcombination of the various features and components described herein. Further, other configurations for a suspension device can be used to perform the uterine suspension procedures described herein, while still remaining within the scope of the invention.
This application is a continuation of, and claims priority to, U.S. patent application Ser. No. 11/535,901, filed on Sep. 27, 2006, entitled “APPARATUS AND METHOD FOR SUSPENDING A UTERUS,” which, in turn, claims priority to U.S. Provisional Application No. 60/721,366, filed on Sep. 28, 2005, entitled “APPARATUS AND METHOD FOR SUSPENDING A UTERUS,” both of which are incorporated by reference herein in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
669034 | Manly | Feb 1901 | A |
2687131 | Raiche | Aug 1954 | A |
3123077 | Alcamo | Mar 1964 | A |
4083369 | Sinnreich | Apr 1978 | A |
4324331 | Ignasiak | Apr 1982 | A |
4792336 | Hlavacek et al. | Dec 1988 | A |
4919667 | Richmond | Apr 1990 | A |
4979956 | Silvestrini | Dec 1990 | A |
4998912 | Scarbrough et al. | Mar 1991 | A |
5013292 | Lemay | May 1991 | A |
5082112 | Dunklee | Jan 1992 | A |
5112344 | Petros | May 1992 | A |
5149329 | Richardson | Sep 1992 | A |
5217466 | Hasson | Jun 1993 | A |
5217486 | Rice et al. | Jun 1993 | A |
5217494 | Coggins et al. | Jun 1993 | A |
5219359 | McQuilkin | Jun 1993 | A |
5263969 | Phillips | Nov 1993 | A |
5356432 | Rutkow et al. | Oct 1994 | A |
5362294 | Seitzinger | Nov 1994 | A |
5364408 | Gordon | Nov 1994 | A |
5383905 | Golds et al. | Jan 1995 | A |
5405359 | Pierce | Apr 1995 | A |
5425747 | Brotz | Jun 1995 | A |
5451235 | Lock et al. | Sep 1995 | A |
5458609 | Gordon et al. | Oct 1995 | A |
5458636 | Brancato | Oct 1995 | A |
5464409 | Mohajer | Nov 1995 | A |
5485917 | Early | Jan 1996 | A |
5527341 | Gogolewski et al. | Jun 1996 | A |
5534008 | Acksel | Jul 1996 | A |
5540704 | Gordon et al. | Jul 1996 | A |
5562689 | Green et al. | Oct 1996 | A |
5569283 | Green et al. | Oct 1996 | A |
5575800 | Gordon | Nov 1996 | A |
5578044 | Gordon et al. | Nov 1996 | A |
5584859 | Brotz | Dec 1996 | A |
5611515 | Benderev et al. | Mar 1997 | A |
5643311 | Smith et al. | Jul 1997 | A |
5662664 | Gordon et al. | Sep 1997 | A |
5683402 | Cosgrove et al. | Nov 1997 | A |
5700272 | Gordon et al. | Dec 1997 | A |
5702397 | Goble et al. | Dec 1997 | A |
5713910 | Gordon et al. | Feb 1998 | A |
5720761 | Kaali | Feb 1998 | A |
5741277 | Gordon et al. | Apr 1998 | A |
5741279 | Gordon et al. | Apr 1998 | A |
5741299 | Rudt | Apr 1998 | A |
5840011 | Landgrebe et al. | Nov 1998 | A |
5871488 | Tovey et al. | Feb 1999 | A |
5899909 | Claren et al. | May 1999 | A |
5922826 | Kuze et al. | Jul 1999 | A |
5931855 | Buncke | Aug 1999 | A |
5948001 | Larsen | Sep 1999 | A |
5976127 | Lax | Nov 1999 | A |
5988549 | Hitomi et al. | Nov 1999 | A |
6010447 | Kardjian | Jan 2000 | A |
6012580 | Peters et al. | Jan 2000 | A |
6039686 | Kovac | Mar 2000 | A |
6042534 | Gellman et al. | Mar 2000 | A |
6042536 | Tihon et al. | Mar 2000 | A |
6042592 | Schmitt | Mar 2000 | A |
6044847 | Carter et al. | Apr 2000 | A |
6048351 | Gordon et al. | Apr 2000 | A |
6096051 | Kortenbach et al. | Aug 2000 | A |
6102921 | Zhu et al. | Aug 2000 | A |
6195646 | Grosh et al. | Feb 2001 | B1 |
6197036 | Tripp et al. | Mar 2001 | B1 |
6200330 | Benderev et al. | Mar 2001 | B1 |
6221005 | Bruckner et al. | Apr 2001 | B1 |
6224616 | Kugel | May 2001 | B1 |
6267772 | Mulhauser et al. | Jul 2001 | B1 |
6273852 | Lehe et al. | Aug 2001 | B1 |
6306079 | Trabucco | Oct 2001 | B1 |
6322492 | Kovac | Nov 2001 | B1 |
6328686 | Kovac | Dec 2001 | B1 |
6346111 | Gordon et al. | Feb 2002 | B1 |
6375662 | Schmitt | Apr 2002 | B1 |
6382214 | Raz et al. | May 2002 | B1 |
6406423 | Scetbon | Jun 2002 | B1 |
6454778 | Kortenbach | Sep 2002 | B2 |
6478727 | Scetbon | Nov 2002 | B2 |
6491703 | Ulmsten | Dec 2002 | B1 |
6502578 | Raz et al. | Jan 2003 | B2 |
6506190 | Walshe | Jan 2003 | B1 |
6530943 | Hoepffner et al. | Mar 2003 | B1 |
6544273 | Harari et al. | Apr 2003 | B1 |
6547800 | Foerster et al. | Apr 2003 | B2 |
6551329 | Kortenbach et al. | Apr 2003 | B1 |
6565580 | Beretta | May 2003 | B1 |
6575897 | Ory et al. | Jun 2003 | B1 |
6575998 | Beyar | Jun 2003 | B2 |
6582443 | Cabak et al. | Jun 2003 | B2 |
6592515 | Thierfelder et al. | Jul 2003 | B2 |
6592610 | Beyar et al. | Jul 2003 | B2 |
6595911 | LoVuolo | Jul 2003 | B2 |
6596001 | Stormby et al. | Jul 2003 | B2 |
6599235 | Kovac | Jul 2003 | B2 |
6599310 | Leung et al. | Jul 2003 | B2 |
6612977 | Staskin et al. | Sep 2003 | B2 |
6638209 | Landgrebe | Oct 2003 | B2 |
6638210 | Berger | Oct 2003 | B2 |
6638211 | Suslian et al. | Oct 2003 | B2 |
6638284 | Rousseau et al. | Oct 2003 | B1 |
6641524 | Kovac | Nov 2003 | B2 |
6641525 | Rocheleau et al. | Nov 2003 | B2 |
6648899 | Kalinski et al. | Nov 2003 | B2 |
6648921 | Anderson et al. | Nov 2003 | B2 |
6652450 | Neisz et al. | Nov 2003 | B2 |
6666817 | Li | Dec 2003 | B2 |
6669706 | Schmitt et al. | Dec 2003 | B2 |
6669735 | Pelissier | Dec 2003 | B1 |
6673010 | Skiba et al. | Jan 2004 | B2 |
6691711 | Raz et al. | Feb 2004 | B2 |
6695855 | Gaston | Feb 2004 | B1 |
6702827 | Lund et al. | Mar 2004 | B1 |
6730110 | Harari et al. | May 2004 | B1 |
6746455 | Beyar et al. | Jun 2004 | B2 |
6752814 | Gellman et al. | Jun 2004 | B2 |
6755781 | Gellman | Jun 2004 | B2 |
6808487 | Migliari | Oct 2004 | B2 |
6830052 | Carter et al. | Dec 2004 | B2 |
6848152 | Genova et al. | Feb 2005 | B2 |
6872227 | Sump et al. | Mar 2005 | B2 |
6881184 | Zappala | Apr 2005 | B2 |
6890338 | Davis et al. | May 2005 | B1 |
6908425 | Luscombe | Jun 2005 | B2 |
6911003 | Anderson et al. | Jun 2005 | B2 |
6911034 | Nobles et al. | Jun 2005 | B2 |
6932759 | Kammerer et al. | Aug 2005 | B2 |
6936052 | Gellman et al. | Aug 2005 | B2 |
6936054 | Chu | Aug 2005 | B2 |
6936952 | Takamine | Aug 2005 | B2 |
6946003 | Wolowacz et al. | Sep 2005 | B1 |
6953428 | Gellman et al. | Oct 2005 | B2 |
6960160 | Browning | Nov 2005 | B2 |
6971986 | Staskin et al. | Dec 2005 | B2 |
6986780 | Rudnick et al. | Jan 2006 | B2 |
6991597 | Gellman et al. | Jan 2006 | B2 |
7011688 | Gryska et al. | Mar 2006 | B2 |
7025772 | Gellman et al. | Apr 2006 | B2 |
7048682 | Neisz et al. | May 2006 | B2 |
7056333 | Walshe | Jun 2006 | B2 |
7070556 | Anderson et al. | Jul 2006 | B2 |
7070558 | Gellman et al. | Jul 2006 | B2 |
7083568 | Neisz et al. | Aug 2006 | B2 |
7083637 | Tannhauser | Aug 2006 | B1 |
7090686 | Nobles et al. | Aug 2006 | B2 |
7094199 | Petros et al. | Aug 2006 | B2 |
7112171 | Rocheleau et al. | Sep 2006 | B2 |
7112210 | Ulmsten et al. | Sep 2006 | B2 |
7122039 | Chu | Oct 2006 | B2 |
7131943 | Kammerer | Nov 2006 | B2 |
7131944 | Jacquetin | Nov 2006 | B2 |
7198597 | Siegel et al. | Apr 2007 | B2 |
7204801 | Grocela | Apr 2007 | B2 |
7204802 | De Leval | Apr 2007 | B2 |
7223229 | Inman et al. | May 2007 | B2 |
7226407 | Kammerer et al. | Jun 2007 | B2 |
7226408 | Harai et al. | Jun 2007 | B2 |
7229453 | Anderson et al. | Jun 2007 | B2 |
7235043 | Gellman et al. | Jun 2007 | B2 |
7244260 | Koseki | Jul 2007 | B2 |
7244759 | Muller et al. | Jul 2007 | B2 |
7267645 | Anderson et al. | Sep 2007 | B2 |
7291104 | Neisz et al. | Nov 2007 | B2 |
7351197 | Montpetit et al. | Apr 2008 | B2 |
7361138 | Wagner et al. | Apr 2008 | B2 |
7364541 | Chu et al. | Apr 2008 | B2 |
7402133 | Chu et al. | Jul 2008 | B2 |
7413540 | Gellman et al. | Aug 2008 | B2 |
7527588 | Zaddem et al. | May 2009 | B2 |
8128552 | O'Donnell | Mar 2012 | B2 |
8911348 | Goldberg et al. | Dec 2014 | B2 |
20010023356 | Raz et al. | Sep 2001 | A1 |
20010049467 | Lehe et al. | Dec 2001 | A1 |
20020010457 | Duchon et al. | Jan 2002 | A1 |
20020028980 | Thierfelder et al. | Mar 2002 | A1 |
20020099259 | Anderson et al. | Jul 2002 | A1 |
20020128670 | Ulmsten et al. | Sep 2002 | A1 |
20020133236 | Rousseau | Sep 2002 | A1 |
20020143234 | LoVuolo | Oct 2002 | A1 |
20020147382 | Neisz et al. | Oct 2002 | A1 |
20020151909 | Gellman et al. | Oct 2002 | A1 |
20020156489 | Gellman et al. | Oct 2002 | A1 |
20030009181 | Gellman et al. | Jan 2003 | A1 |
20030023138 | Luscombe | Jan 2003 | A1 |
20030023250 | Watschke et al. | Jan 2003 | A1 |
20030050530 | Neisz et al. | Mar 2003 | A1 |
20030055313 | Anderson et al. | Mar 2003 | A1 |
20030078604 | Walshe | Apr 2003 | A1 |
20030125715 | Kuehn et al. | Jul 2003 | A1 |
20030149334 | Ulmsten et al. | Aug 2003 | A1 |
20030176762 | Kammerer | Sep 2003 | A1 |
20030191360 | Browning | Oct 2003 | A1 |
20030208208 | Chu | Nov 2003 | A1 |
20030220538 | Jacquetin | Nov 2003 | A1 |
20030225424 | Benderev | Dec 2003 | A1 |
20030233107 | Gellman et al. | Dec 2003 | A1 |
20030233108 | Gellman et al. | Dec 2003 | A1 |
20040006353 | Bosley et al. | Jan 2004 | A1 |
20040015048 | Neisz et al. | Jan 2004 | A1 |
20040015177 | Chu | Jan 2004 | A1 |
20040034372 | Chu | Feb 2004 | A1 |
20040039246 | Gellman et al. | Feb 2004 | A1 |
20040039453 | Anderson et al. | Feb 2004 | A1 |
20040059293 | Chu et al. | Mar 2004 | A1 |
20040068159 | Neisz et al. | Apr 2004 | A1 |
20040073234 | Chu et al. | Apr 2004 | A1 |
20040087970 | Chu et al. | May 2004 | A1 |
20040106847 | Benderev | Jun 2004 | A1 |
20040116944 | Chu et al. | Jun 2004 | A1 |
20040133217 | Watschke | Jul 2004 | A1 |
20040138747 | Kaladelfos | Jul 2004 | A1 |
20040181243 | Chu et al. | Sep 2004 | A1 |
20040186515 | Rosenblatt | Sep 2004 | A1 |
20040225181 | Chu et al. | Nov 2004 | A1 |
20040230206 | Gellman et al. | Nov 2004 | A1 |
20040231678 | Fierro | Nov 2004 | A1 |
20040236356 | Rioux et al. | Nov 2004 | A1 |
20040249397 | Delorme et al. | Dec 2004 | A1 |
20040249473 | Delorme et al. | Dec 2004 | A1 |
20050004427 | Cervigni | Jan 2005 | A1 |
20050004576 | Benderev | Jan 2005 | A1 |
20050038451 | Rao et al. | Feb 2005 | A1 |
20050038452 | Chu | Feb 2005 | A1 |
20050075660 | Chu et al. | Apr 2005 | A1 |
20050080317 | Merade | Apr 2005 | A1 |
20050090706 | Gellman et al. | Apr 2005 | A1 |
20050096499 | Li et al. | May 2005 | A1 |
20050101834 | Merade | May 2005 | A1 |
20050107805 | Bouffier et al. | May 2005 | A1 |
20050131391 | Chu et al. | Jun 2005 | A1 |
20050131392 | Chu et al. | Jun 2005 | A1 |
20050131393 | Chu et al. | Jun 2005 | A1 |
20050177022 | Chu et al. | Aug 2005 | A1 |
20050192600 | Nicolo et al. | Sep 2005 | A1 |
20050222589 | Chu | Oct 2005 | A1 |
20050222591 | Gingras et al. | Oct 2005 | A1 |
20050234291 | Gingras | Oct 2005 | A1 |
20050245787 | Cox et al. | Nov 2005 | A1 |
20050250977 | Montpetit et al. | Nov 2005 | A1 |
20050250978 | Kammerer | Nov 2005 | A1 |
20050256366 | Chu | Nov 2005 | A1 |
20050256530 | Petros | Nov 2005 | A1 |
20050261545 | Gellman et al. | Nov 2005 | A1 |
20050261547 | Bouffier | Nov 2005 | A1 |
20050277807 | MacLean et al. | Dec 2005 | A1 |
20050278037 | Delorme et al. | Dec 2005 | A1 |
20060015001 | Staskin et al. | Jan 2006 | A1 |
20060025649 | Smith et al. | Feb 2006 | A1 |
20060025783 | Smith et al. | Feb 2006 | A1 |
20060041185 | Browning | Feb 2006 | A1 |
20060041263 | Chu et al. | Feb 2006 | A1 |
20060052801 | Dreyfuss et al. | Mar 2006 | A1 |
20060058574 | Priewe et al. | Mar 2006 | A1 |
20060058575 | Zaddem et al. | Mar 2006 | A1 |
20060069301 | Neisz et al. | Mar 2006 | A1 |
20060089524 | Chu | Apr 2006 | A1 |
20060089525 | Mamo et al. | Apr 2006 | A1 |
20060122457 | Kovac et al. | Jun 2006 | A1 |
20060173237 | Jacquetin | Aug 2006 | A1 |
20060205995 | Browning | Sep 2006 | A1 |
20060211911 | Jao et al. | Sep 2006 | A1 |
20060229493 | Weiser et al. | Oct 2006 | A1 |
20060229596 | Weiser et al. | Oct 2006 | A1 |
20060264698 | Kondonis et al. | Nov 2006 | A1 |
20070043255 | O'Donnell | Feb 2007 | A1 |
20070055095 | Chu et al. | Mar 2007 | A1 |
20070161849 | Goldberg | Jul 2007 | A1 |
20070173864 | Chu | Jul 2007 | A1 |
20070270890 | Miller | Nov 2007 | A1 |
20070276358 | Barzell et al. | Nov 2007 | A1 |
20080177132 | Alinsod et al. | Jul 2008 | A1 |
20080234543 | Goldwasser | Sep 2008 | A1 |
20090171142 | Chu | Jul 2009 | A1 |
20090171143 | Chu et al. | Jul 2009 | A1 |
20100130814 | Dubernard | May 2010 | A1 |
20100152530 | Timmer et al. | Jun 2010 | A1 |
20110112357 | Chapman et al. | May 2011 | A1 |
20120136324 | Hanuka et al. | May 2012 | A1 |
20130066145 | Fairneny et al. | Mar 2013 | A1 |
20150094527 | Goldberg et al. | Apr 2015 | A1 |
Number | Date | Country |
---|---|---|
10056169 | Jun 2002 | DE |
0088714 | Sep 1983 | EP |
0141589 | May 1985 | EP |
0299158 | Jan 1989 | EP |
0362146 | Apr 1990 | EP |
0412664 | Feb 1991 | EP |
0567130 | Oct 1993 | EP |
0774240 | May 1997 | EP |
1201189 | May 2002 | EP |
1508305 | Feb 2005 | EP |
1520554 | Apr 2005 | EP |
1609439 | Dec 2005 | EP |
1933786 | Jun 2008 | EP |
2617385 | Jul 2013 | EP |
1998711 | Dec 2013 | EP |
2785521 | May 2000 | FR |
2852817 | Oct 2004 | FR |
2852818 | Oct 2004 | FR |
2871365 | Dec 2005 | FR |
670349 | Apr 1952 | GB |
06114067 | Apr 1994 | JP |
08117239 | May 1996 | JP |
PA04008407 | Dec 2005 | MX |
9609796 | Apr 1996 | WO |
9639948 | Dec 1996 | WO |
9835616 | Aug 1998 | WO |
9835632 | Aug 1998 | WO |
9843545 | Oct 1998 | WO |
9937216 | Jul 1999 | WO |
0009039 | Feb 2000 | WO |
0074613 | Dec 2000 | WO |
0074594 | Dec 2000 | WO |
0106951 | Feb 2001 | WO |
0152135 | Jul 2001 | WO |
0231681 | Apr 2002 | WO |
0232284 | Apr 2002 | WO |
0238079 | May 2002 | WO |
02058563 | Aug 2002 | WO |
02062237 | Aug 2002 | WO |
02078571 | Oct 2002 | WO |
03068107 | Aug 2003 | WO |
03073960 | Sep 2003 | WO |
03092546 | Nov 2003 | WO |
03096928 | Nov 2003 | WO |
03096929 | Nov 2003 | WO |
2004001619 | Dec 2003 | WO |
2004012626 | Feb 2004 | WO |
2004016196 | Feb 2004 | WO |
2004091442 | Oct 2004 | WO |
2004091443 | Oct 2004 | WO |
2005051204 | Jun 2005 | WO |
2005122721 | Dec 2005 | WO |
2005122954 | Dec 2005 | WO |
2006046950 | May 2006 | WO |
2007014240 | Feb 2007 | WO |
2007016698 | Feb 2007 | WO |
2007019374 | Feb 2007 | WO |
2007014240 | Feb 2007 | WO |
2007016698 | Feb 2007 | WO |
2007038589 | Apr 2007 | WO |
2007059199 | May 2007 | WO |
2007087132 | Aug 2007 | WO |
2007087132 | Aug 2007 | WO |
Entry |
---|
Non-Final Office Action for U.S. Appl. No. 11/686,683, mailed on Jul. 8, 2009, 13 pages. |
Final Office Action for U.S. Appl. No. 11/686,683, mailed on Jan. 19, 2010, 15 pages. |
Non-Final Office Action for U.S. Appl. No. 11/331,777, mailed on Apr. 21, 2008, 11 pages. |
Final Office Action for U.S. Appl. No. 11/331,777, mailed on Oct. 14, 2008, 15 pages. |
Non-Final Office Action for U.S. Appl. No. 11/331,777, mailed on May 8, 2009, 14 pages. |
Final Office Action for U.S. Appl. No. 11/331,777, mailed on Dec. 8, 2009, 16 pages. |
Advisory Action for U.S. Appl. No. 11/331,777, mailed on Mar. 10, 2009, 4 pages. |
Advisory Action for U.S. Appl. No. 11/331,777, mailed on Feb. 17, 2010, 4 pages. |
Non-Final Office Action for U.S. Appl. No. 11/493,148, mailed on Sep. 24, 2008, 12 pages. |
Non-Final Office Action for U.S. Appl. No. 11/493,148, mailed on Jun. 5, 2009, 14 pages. |
Final Office Action for U.S. Appl. No. 11/493,148, mailed on Dec. 17, 2009, 13 pages. |
Non-Final Office Action for U.S. Appl. No. 11/493,148, mailed on Mar. 25, 2010, 14 pages. |
Final Office Action for U.S. Appl. No. 11/493,148, mailed on Jul. 12, 2010, 14 pages. |
Notice of Allowance for U.S. Appl. No. 11/493,148, mailed on Sep. 30, 2010, 6 pages. |
European Office Action for EP Patent Application No. 07716311.1, mailed on Dec. 8, 2009, 3 pages. |
Notice of Allowance for U.S. Appl. No. 11/535,901, mailed on Sep. 21, 2010, 26 pages. |
“Capio® CL Transvaginal Suture Capturing Device”, The Capio CL Transvaginal Suture Capturing Device allows for a transvaginal suture fixation to Cooper's Ligament for Sling Procedures, Boston Scientific, printed on Apr. 7, 2006, 2 pages. |
“Capio® CL Transvaginal Suture Capturing Device”, Transvaginal Suture Fixation to Cooper's Ligament for Sling Procedures, Boston Scientific, 2000, 4 pages. |
“Capio® Open Access and Standard Suture Capturing Devices”, Reach, Throw and Capture: One Step. One Device., Boston Scientific, printed on Apr. 7, 2006, 2 pages. |
“Capio® RP Suture Device”, Boston Scientific, printed on Apr. 7, 2006, 1 page. |
“Capio® RP Suture Device”, The Capio RP Suturing Device is designed to assist with anastomosis after a radical prostatectomy, undated,1 page. |
“Capio® Suture Capturing Devices”, Reach, Throw and Capture: One Step. One Device., Boston Scientific, 2005, 4 pages. |
International Search Report for PCT Application No. PCT/FR2004/000765, mailed on Dec. 28, 2004, 10 pages. |
International Search Report and Written Opinion of the International Searching Authority received for PCT Application No. PCT/US2007/000190, mailed on Jul. 3, 2007, 9 pages. |
International Search Report received for PCT Application No. PCT/AU2004/001674, mailed on Dec. 21, 2004, 3 pages. |
International Search Report received for PCT Application No. PCT/FR2004/000766, mailed on Aug. 11, 2004, 9 pages. |
International search Report received for PCT Application No. PCT/US2001/031234, mailed on Dec. 14, 2001, 1 page. |
International Search Report received for PCT Application No. PCT/US2001/30033, mailed on May 10, 2002, 1 page. |
International search report received for PCT Application No. PCT/US2006/028963, mailed on Dec. 6, 2006, 3 pages. |
International Search Report received for PCT Application No. PCT/US2007/000190, mailed on Jul. 3, 2007, 5 pages. |
International Search Report received for PCT Application No. PCT/US2005/021267, mailed on Nov. 30, 2005, 6 pages. |
European Search Report received for EP Patent Application No. EP 01117717, mailed on Apr. 18, 2007, 5 pages. |
European Search Report received for EP Patent Application No. EP 90307704, mailed on Apr. 18, 2007, 1 page. |
Search report received for French Patent Application No. FR0406352, mailed on Jan. 13, 2005, 3 pages. |
European Search Report received for EP Patent Application No. EP 05356101, mailed on Nov. 1, 2005, 2 pages. |
Search report received for French Patent Application No. FR 0303893, mailed on Jan. 21, 2004, 2 pages. |
Search report received for French Patent Application No. FR 0303895, mailed on Jan. 21, 2004, 3 pages. |
International Search Report received for PCT Application No. PCT/US1998/03066, mailed on May 28, 1998, 2 pages. |
International Search report received for PCT Application No. PCT/US2004/035329, mailed on Jul. 7, 2005, 7 pages. |
Notification Concerning Transmittal of Copy of International Preliminary Report on Patentability (Chapter I of the Patent Cooperation Treaty) issued in corresponding International Application No. PCT/US2007/000190, mailed on Jul. 24, 2008. |
International Search Report received for PCT Application No. PCT/US2007/064079 mailed on Aug. 28, 2007, 4 pages. |
Final Office Action received for U.S. Appl. No. 11/535,901, mailed on Jan. 29, 2009, 22 pages. |
Non-Final Office Action received for U.S. Appl. No. 11/535,901, mailed on Jun. 9, 2009, 22 pages. |
Leron, E. et al., “Sacrohysteropexy with synthetic mesh for the management of uterovaginal prolapse”, British Journal of Obstetrics and Gynaecology, 108.3, 2001, pp. 629-633. |
Final Office Action for U.S. Appl. No. 11/686,683, mailed Nov. 5, 2012, 32 pages. |
Non-Final Office Action for U.S. Appl. No. 11/686,683, mailed Aug. 13, 2013, 26 pages. |
Non-Final Office Action for U.S. Appl. No. 13/218,840, mailed Jun. 7, 2013, 11 pages. |
Non-Final Office Action Response for U.S. Appl. No. 13/218,840, filed Sep. 3, 2013, 9 pages. |
Final Office Action Response for U.S. Appl. No. 11/686,683, filed Feb. 5, 2013, 17 pages. |
Pohl, et al, “Bilateral Transvaginal Sacrospinous Colpopexy: Preliminary Experience”, 23rd Annual Meeting of the Society of Gynecologic Surgeons, Feb. 24-26, 1997, 7 pages. |
Shah, et al, “Short-Term Outcome Analysis of Total Pelvic Reconstruction With Mesh: The Vaginal Approach”, The Journal of Urology, vol. 171, Jan. 2004, pp. 261-263. |
Hardiman, et al, “Sacrospinous Vault Suspension and Abdonimal Colposacropexy: Success Rates and Complications”, Section of Urogynecology, Department of Obstetrics and Gynecology, University of Toronto, Mount Sinai Hospital, Sep. 18, 1995, 5 pages. |
Non Final Office Action for U.S. Appl. No. 11/331,777, mailed on Dec. 6, 2013, 18 pages. |
Response to Non Final Office Action for U.S. Appl. No. 11/331,777, filed Mar. 6, 2014, 8 pages. |
Final Office Action for U.S. Appl. No. 11/331,777, mailed on Apr. 14, 2014, 18 pages. |
Final Office Action for U.S. Appl. No. 13/218,840, mailed on Dec. 24, 2013, 11 pages. |
Response to Final Office Action for U.S. Appl. No. 13/218,840, filed Mar. 24, 2014, 12 pages. |
Notice of Allowance for U.S. Appl. No. 13/218,840, mailed on May 1, 2014, 7 pages. |
Final Office Action for U.S. Appl. No. 11/686,683, mailed on Feb. 25, 2014, 29 pages. |
Response to Non Final Office Action for U.S. Appl. No. 11/686,683, filed Nov. 13, 2013, 13 pages. |
Response to Office Action for European Patent Application No. 07758616.2, filed on Oct. 17, 2011, 31 pages. |
Office Action for European Patent Application No. 06815573.8, mailed on Nov. 15, 2013, 3 pages. |
International Preliminary Report on Patentability for PCT Application No. PCT/US2011/49753, mailed on Mar. 14, 2013, 9 pages. |
Extended European Search Report for EP Application No. 13164488.2, mailed Jul. 31, 2014, 6 pages. |
Non-Final Office Action for U.S. Appl. No. 13/606,883, mailed Aug. 1, 2014, 18 pages. |
Notice of Allowance for U.S. Appl. No. 13/218,840, mailed Aug. 15, 2014, 7 pages. |
Non-Final Office Action for U.S. Appl. No. 11/686,683, mailed Jun. 17, 2014, 31 pages. |
Response to Final Office Action for U.S. Appl. No. 11/686,683, filed May 23, 2014, 15 pages. |
Response to Final Office Action for U.S. Appl. No. 11/331,777, filed Jul. 11, 2014, 13 pages. |
Non-Final Office Action for U.S. Appl. No. 11/331,777, dated Sep. 29, 2014, 19 pages. |
Response to Non-Final Office Action for U.S. Appl. No. 11/331,777, filed Dec. 26, 2014, 7 pages. |
Final Office Action for U.S. Appl. No. 11/331,777, mailed on Mar. 3, 2015, 14 pages. |
Final Office Action for U.S. Appl. No. 11/686,683, mailed on Dec. 23, 2014, 18 pages. |
Response to Final Office Action for U.S. Appl. No. 11/686,683, filed Feb. 23, 2015, 12 pages. |
Notice of Allowance for U.S. Appl. No. 11/686,683, mailed on Mar. 13, 2015, 7 pages. |
Final Office Action for U.S. Appl. No. 13/606,883, mailed on Mar. 30, 2015, 23 pages. |
Number | Date | Country | |
---|---|---|---|
20110098527 A1 | Apr 2011 | US |
Number | Date | Country | |
---|---|---|---|
60721366 | Sep 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11535901 | Sep 2006 | US |
Child | 12983666 | US |